Neoadjuvant Study With Combination Immuno-oncology for Primary Clear Cell Renal Cell Cancer
Neoadjuvant Study With Combination Immuno-oncology for Primary Clear Cell Renal Cell Cancer
Active, not recruiting · NCT05148546 · Registry updated 2025-09-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Neoadjuvant Study With Combination Immuno-oncology for Primary Clear Cell Renal Cell Cancer | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, benign urinary system neoplasm, carcinoma, epithelial neoplasm, kidney cancer, kidney disorder, neoplasm, renal cell carcinoma, urinary system disorder | Active, not recruiting | Phase 2 | 2025-09-30 | NCT05148546 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Bristol-Myers Squibb | 422 |
| The Netherlands Cancer Institute | 113 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Netherlands Cancer Institute | Amsterdam | Netherlands | 4 |
| Royal Free London NHS Foundation Trust | London | United Kingdom | 17 |